Tokyo, March 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060985) titled 'ZURZUVAE Capsules 30mg Drug Use-results Survey' on March 19.
Study Type:
Observational
Primary Sponsor:
Institute - Shionogi & Co., Ltd.
Condition:
Condition - Depression or Depressed State
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To collect the safety and the efficacy of ZURZUVAE Capsules under clinical practice
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patient with depression or depressed state who has not been treated with ZURZUVAE Capsules and provides an informed consent in written for data collection and analysis
Key exclusion criteria - NA
Target Size - 1500
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 02 Day
Anticipated trial start date - 2026 Year 04 Month 30 Day
Last follow-up date - 2029 Year 02 Month 28 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069788
Disclaimer: Curated by HT Syndication.
